Search Results

52 results were found

Activity Type CME Provider Title Credit Hours Fee End Date
Reset sort order
JAMA Oncology Obstacles to Biosimilar Acceptance and Uptake in Oncology - A Review 1 Yes 5/30/2027
JAMA Oncology Lymphoma With a Skin Rash 1 Yes 6/6/2027
JAMA Oncology Current Management of Desmoid Tumors - A Review 1 Yes 6/20/2027
JAMA Oncology A Case of Gastric Thickening and a Large Ovarian Mass 1 Yes 6/27/2027
JAMA Oncology Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer - The FAST Multidisciplinary Group Consensus Statement 1 Yes 7/11/2027
JAMA Oncology BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients - A Review 1 Yes 7/25/2027
JAMA Oncology Contemporary Management of Acute Myeloid Leukemia - A Review 1 Yes 8/8/2027
JAMA Oncology An Anal Lesion in a 27-Year-Old Patient 1 Yes 8/22/2027
JAMA Oncology Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers - A Systematic Review 1 Yes 8/29/2027
JAMA Oncology Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer - A Review 1 Yes 9/12/2027
JAMA Oncology Recurrent Fevers in a Patient With Splenomegaly 1 Yes 9/26/2027
JAMA Oncology Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs 1 Yes 10/3/2027
JAMA Oncology Endometrial Cancer Classification and Management in the Molecular Subtyping Era 1 Yes 10/10/2027
JAMA Oncology Hairy Kidneys and Sclerotic Bone Lesions 1 Yes 10/24/2027
JAMA Oncology Advancing Global Pharmacoequity in Oncology 1 Yes 11/14/2027
JAMA Oncology Targeting CNS Metastases in Non–Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers - A Review 1 Yes 11/27/2027
JAMA Oncology Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy - A Review 1 Yes 12/12/2027
JAMA Oncology Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors - A Review 1 Yes 12/26/2027
JAMA Oncology Biomarker-Directed Radiotherapy in Breast Cancer - A Narrative Review 1 Yes 1/16/2028
JAMA Oncology Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma - A Narrative Review 1 Yes 2/6/2028